See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.

See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.

2025年8月20日 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

Pharmacology Vesicular monoamine transporter 2 (VMAT2) is a protein that regulates the packaging and release of monoamines (dopamine, serotonin, norepinephrine, and histamine). VMAT2 inhibitors …

2025年12月17日 · Akathisia and tardive dyskinesia are medication-related movement disorders with distinct causes and treatments. Learn the signs and risks.

2025年12月8日 · Tardive dyskinesia is a side effect that causes uncontrollable, repetitive body movements. It is caused by long-term use of antipsychotic medications.

2025年11月12日 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.

2024年5月30日 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …

2025年9月21日 · Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine)...

2025年11月10日 · Discover what is the medication for tardive dyskinesia Austedo (deutetrabenazine), its mechanism of action as a VMAT2 inhibitor, side effects, and how it treats involuntary movements.